JP7832745B2 - 網膜色素上皮細胞の保護剤 - Google Patents
網膜色素上皮細胞の保護剤Info
- Publication number
- JP7832745B2 JP7832745B2 JP2025551481A JP2025551481A JP7832745B2 JP 7832745 B2 JP7832745 B2 JP 7832745B2 JP 2025551481 A JP2025551481 A JP 2025551481A JP 2025551481 A JP2025551481 A JP 2025551481A JP 7832745 B2 JP7832745 B2 JP 7832745B2
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- amino acid
- acid sequence
- pigment epithelial
- retinal pigment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023175613 | 2023-10-11 | ||
| JP2023175613 | 2023-10-11 | ||
| PCT/JP2024/035711 WO2025079538A1 (ja) | 2023-10-11 | 2024-10-04 | 網膜色素上皮細胞の保護剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2025079538A1 JPWO2025079538A1 (cg-RX-API-DMAC7.html) | 2025-04-17 |
| JP7832745B2 true JP7832745B2 (ja) | 2026-03-18 |
| JPWO2025079538A5 JPWO2025079538A5 (cg-RX-API-DMAC7.html) | 2026-03-19 |
Family
ID=95395811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025551481A Active JP7832745B2 (ja) | 2023-10-11 | 2024-10-04 | 網膜色素上皮細胞の保護剤 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7832745B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2025079538A1 (cg-RX-API-DMAC7.html) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160015770A1 (en) | 2013-03-13 | 2016-01-21 | The Regents Of The University Of Michigan | Compositions for treatment of retinal detachment |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6183879B2 (ja) * | 2012-08-31 | 2017-08-23 | 国立大学法人弘前大学 | 新規ペプチドおよびその医薬用途 |
-
2024
- 2024-10-04 JP JP2025551481A patent/JP7832745B2/ja active Active
- 2024-10-04 WO PCT/JP2024/035711 patent/WO2025079538A1/ja not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160015770A1 (en) | 2013-03-13 | 2016-01-21 | The Regents Of The University Of Michigan | Compositions for treatment of retinal detachment |
Non-Patent Citations (3)
| Title |
|---|
| DENG Yanhui et al.,Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy,Genes & Diseases,2022年,Vol. 9, No. 1,Pages 62-79,DOI: 10.1016/j.gendis.2021.02.009 |
| ZHANG Shuaishuai et al.,Calpain-2 Facilitates Autophagic/Lysosomal Defects and Apoptosis in ARPE-19 Cells and Rats Induced by Exosomes from RPE Cells under NaIO3 Stimulation,Oxidative Medicine and Cellular Longevity,2023年01月,Vol. 2023, Article ID: 3310621,Pages 1-18,DOI: 10.1155/2023/3310621 |
| 尾崎拓,ミトコンドリアカルパインの生理機能の解明と加齢に伴う神経変性疾患に対する治療薬の創出,Hi!こちら岩手大学,2021年,Vol.47,Page 1 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025079538A1 (ja) | 2025-04-17 |
| JPWO2025079538A1 (cg-RX-API-DMAC7.html) | 2025-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5244584B2 (ja) | キサンタンガムおよびブドウ糖を含有する眼科用組成物 | |
| JP7695277B2 (ja) | 安定なペプチド組成物 | |
| JP7330510B2 (ja) | 非滲出型または萎縮型の黄斑変性にて以前に失われた視力を回復させるための医薬組成物 | |
| JP4682495B2 (ja) | 眼疾患の予防、治療剤 | |
| WO2010113753A1 (ja) | JNK(c-Junアミノ末端キナーゼ)阻害ペプチドを用いた網膜疾患の予防または治療剤、網膜疾患の予防または治療方法、ならびに、その使用 | |
| JP2009535329A5 (cg-RX-API-DMAC7.html) | ||
| CN102105167A (zh) | 轴性近视的预防或治疗剂 | |
| JPWO2001017527A1 (ja) | 眼疾患の予防、治療剤 | |
| CN106943590B (zh) | 一种包含ngf的用于治疗角膜上皮损伤的药物组合物 | |
| WO2025079538A1 (ja) | 網膜色素上皮細胞の保護剤 | |
| US20150031712A1 (en) | Therapeutic Compositions Containing Dipyridamole and Treatment Packs Including Such Compositions and Methods for Producing Same | |
| WO2002040028A1 (fr) | Gouttes pour les yeux en gel antibacterien | |
| HU221592B (hu) | Eljárás száraz szem helyi kezelésére alkalmas, hatóanyagként karbakol-kloridot tartalmazó gyógyszerkészítmény előállítására | |
| KR102429281B1 (ko) | 신규 안구건조증 치료용 약학적 조성물 | |
| TWI901889B (zh) | 胱胺的用途 | |
| AU2017206626A1 (en) | Pharmaceutical formulations and their use for the treatment of retinitis pigmentosa | |
| US20250161403A1 (en) | Peptides and methods of use thereof in treating ocular disorders | |
| CA2817505C (en) | Pharmaceutical formulation having neuroprotective activity | |
| RU2788097C2 (ru) | Терапевтические и нейропротекторные пептиды | |
| WO2007148744A1 (ja) | フマル酸誘導体を有効成分として含む角結膜障害の予防または治療剤 | |
| JP4393863B2 (ja) | 視神経細胞保護剤 | |
| RU2118523C1 (ru) | Офтальмологическое средство преимущественно для лечения глаукомы | |
| JP2000319194A (ja) | 乾性角膜症治療剤 | |
| HK40107693A (en) | Trpa1 channel antagonist compound for use in degenerative retinal diseases | |
| WO2025010288A3 (en) | Hyaluronic acid based drug delivery systems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260117 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20260117 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20260117 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260210 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260227 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260307 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7832745 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |